Sort
39,280 grants matching “leukemia”
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
$663,135Martin Carroll · University Of Pennsylvania · R01 · FY2018 · CA
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
$663,135Martin Carroll · University Of Pennsylvania · R01 · FY2017 · CA
Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia
$663,135Martin Carroll · University Of Pennsylvania · R01 · FY2016 · CA
Immunobiology of Normal and Neoplastic Lymphocytes
$662,948Warren S Pear · University Of Pennsylvania · T32 · FY2023 · CA
Dysregulated epigenetic control in leukemogenesis
$662,938Yan Liu · Northwestern University At Chicago · R01 · FY2025 · CA
Clinical and Molecular Heterogeneity in the Myelodysplastic Syndromes
$662,916Christopher Y Park · New York University School Of Medicine · R01 · FY2024 · CA
Retrovirus Assembly and Maturation
$662,874Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Humoral immunity after CAR-T cell therapy for B cell malignancies: The HICAR Study
$662,560Joshua Aiden Hill · Fred Hutchinson Cancer Research Center · U01 · FY2021 · CA
Mechanisms of Leukemogenesis in AMKL
$662,414Diane S. Krause · Yale University · R01 · FY2023 · CA
Exploiting the VISTA Pathway to Prevent Acute GVHD and Control Steroid Refractory Disease
$662,404Bruce R. Blazar · University Of Minnesota · R01 · FY2022 · HL
Germline and Somatic Genomic Studies in CLL
$662,342Susan L Slager · Mayo Clinic Rochester · R01 · FY2025 · CA
Efficacy and immune effects of anakinra prophylaxis for neurologic toxicity and cytokine release syndrome in patients with lymphoma receiving axicabtagene ciloleucel
$662,340Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2024 · CA
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$662,151Susan L Slager · Mayo Clinic Rochester · U01 · FY2012 · CA
MECHANISMS OF BONE MARROW FAILURE AND LEUKEMIA PROGRESSION IN PRIMARY HUMAN FANCONI ANEMIA STEM CELLS IN NOVEL FA PDX MODEL
$662,114Yale Univ · · FY2018 · Department of the Army
Development of P2Y Receptor Ligands
$662,094Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies
$661,706Iris Z Jaffe · Tufts Medical Center · R01 · FY2023 · HL
Molecular strategies for early detection and targeting of cancer
$661,639Tannishtha Reya · Columbia University Health Sciences · R35 · FY2022 · CA
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
$661,623John F Dipersio · Washington University · R35 · FY2017 · CA
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
$661,549William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2009 · CA
New tools for quantitative non-invasive recording of biochemical signals
$661,301Nathan Christopher Shaner · University Of California, San Diego · R01 · FY2025 · CA
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
$661,289Wendell A Lim · University Of California, San Francisco · R01 · FY2017 · CA
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
$661,289Wendell A Lim · University Of California, San Francisco · R01 · FY2018 · CA
Redesigning the T cell: Using Synthetic Biology to Engineer Therapeutic Cells
$661,149Wendell A Lim · University Of California, San Francisco · R01 · FY2016 · CA
Studies of Proteins with Important Roles in Immunology andor Cancer Biology
$661,102Jacek T Lubkowski · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Cytokines and T Cell Development
$661,045Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA